Navigation Links
HumanWare introduces four new portable video magnifiers for low vision
Date:7/8/2008

LONGUEUIL, QC, July 8 /PRNewswire/ - HumanWare expands its low vision product line with the announcement of four new video magnifiers at Vision 2008, an international conference on low vision being held in Montreal this week. With these new products, HumanWare is better able to serve the needs of the growing number of people with low vision - those whose vision cannot be completely corrected even with the most powerful prescription glasses.

HumanWare's new video magnifiers are designed to meet the needs of different environments and applications. Each product offers unique features to improve the user's independence.

The new products include:

SmartView Pocket. an extremely lightweight handheld video magnifier that can be used in the home or around town, wherever things are too small to see. Large, intuitive buttons make the unit easy to use. The Pocket provides up to 9x magnification on its 3.6-inch LCD screen.

SmartView Graduate. Ideally suited for helping low vision students fully participate in class by being able to see across the room and magnify items on their desk. The Graduate connects to a notebook computer via a USB interface to provide up to 50x magnification on the computer screen. The camera turns to view the desktop or distant objects. The unit easily fits into a computer bag and weighs only 2.5 pounds, which makes it extremely easy to carry between classes.

SmartView Nano. The smallest video magnifier available at a very affordable price. The Nano magnifies objects from 5x to 20x, making it easy to read fine print on pill bottles, ingredients on product labels, or seat numbers on theater tickets.

SmartView Mobile. A portable video magnifier with a 7-inch screen, providing up to 18x magnification. The Mobile is ideal for those who need a portable device but cannot compromise on magnification and screen size. Perfect for taking to the library, carrying around home or using at the office.

"With thes
'/>"/>

SOURCE HUMANWARE
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Delta Dental of Illinois Introduces Smile Smart For Your Health
2. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
3. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
4. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
5. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
6. Triveris Introduces Personal Health Record with Built-in Health Advisor
7. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
8. Mecklenburg EMS Introduces Most-Advanced Situational Training in America for Emergency Medical Personnel
9. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
10. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
11. ThermoTx Introduces New Mobile Stimulation (TENS) Product Line for On the Go Therapy and Pain Relief
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 2RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 3AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Skincare Industry Newcomer Shines 51058 1Skincare Industry Newcomer Shines 51058 2For Treatment of Dyslipidemia Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials 51055 1For Treatment of Dyslipidemia Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials 51055 2For Treatment of Dyslipidemia Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials 51055 3Allied World Schedules Second Quarter 2009 Earnings Announcement and Conference Call 51052 1